Tuesday, 9 June 2020

Worldwide Cerebral Palsy Market Top 10 Players Universal Analysis, Industry Demand And 2023 Forecast

Market Scenario
Cerebral palsy (CP) is a group of lifelong neurological disorders that affect movement and coordination, caused by damage to or abnormalities inside the developing brain of the infant. CP can occur before, during or soon after birth. Additionally, cerebral palsy can develop from several factors such as lack of oxygen to the brain, genetic conditions, brain infections, brain hemorrhage, chemical or substance abuse during pregnancy, injury to the head, and severe jaundice.
The global cerebral palsy treatment market is driving owing to the growing prevalence of cerebral palsy coupled with increasing awareness about the condition. Moreover, the growing adoptions of medications for controlling the symptoms of the cerebral palsy are anticipated to propel the market growth. Additionally, increasing expenditure for the healthcare sector in developed economies and increasing insurance coverage contribute to the growth of the market.
Despite the drivers, side effects associated with medications and high treatment cost and lack of awareness in some developing regions may hamper the market growth during the assessment period.
Regional Summary
The Americas is expected to dominate the global cerebral palsy market during the forecast period owing to the well-established healthcare sector, growing awareness about CP, and the rising prevalence of cerebral palsy in the region. The European market is expected to be the second-largest market due to the growing healthcare expenditure and increasing prevalence of cerebral palsy. Moreover, the market in Asia-Pacific is anticipated to be the fastest-growing during the forecast period owing to the developing healthcare infrastructure, and favorable government initiatives for the healthcare sector. The Middle East & Africa is likely to account for the least cerebral palsy market share over global market owing to the lack of economic development, especially in the African region.
Key players
Some of the prominent players in the global cerebral palsy market are Allergen Plc, Cellular Biomedicine Group, Merck & Co., Inc., Pfizer, Inc., GlaxoSmithKline Plc, Abbott Laboratories, Acorda Therapeutics, Inc., Medtronic, Meridigen Biotech Co., Ltd., GW Pharmaceuticals Plc, and Cell Cure Neurosciences Ltd.
Segmentation
The global cerebral palsy market has been segmented into type, diagnosis, and treatment.
The market, on the basis of type, has been segmented into spastic cerebral palsy, dyskinetic cerebral palsy, hypotonic cerebral palsy, ataxic cerebral palsy, and mixed cerebral palsy.
The market, by diagnosis, has been segmented into imaging tests and others. The imaging tests have been further segmented into magnetic resonance imaging (MRI), cranial ultrasound, computed tomography, and electroencephalogram.
The market, by treatment, has been segmented into therapy, medication, surgery, and others. The therapy segment has been segmented into nutrition therapy, hyperbaric oxygen therapy, occupational therapy, physical therapy, stem cell therapy, and others. The medication segment has been segmented into anti-convulsant drugs, muscle relaxants, anti-depressant drugs, anti-inflammatory drugs, and others. Further, the surgery segment has been segmented into orthopedic surgery and others.
Posted by at No comments:

Worldwide Neurostimulation Devices Market Segmentation And Analysis By Recent Trends And Growth Prospects By Regions To 2022

Market Scenario:
Neurostimulation is a modulation of the nervous system’s activity. It is deliberately carried out by using invasive and non-invasive techniques. Implantable stimulation devices are most commonly used in the treatment of the neurological conditions such as epilepsy, Parkinson’s disease, dystonia, tremors, depression, obsessive compulsive disorder, diabetic neuropathy and few other conditions. Increasing cases of the neurological disorders such as chronic pain and depression high adoption of the Neurostimulation therapy are likely to improve the market of Neurostimulation devices. Globally, this Neurostimulation Devices Market Size is growing steadily and it is anticipated to show an exponential growth reaching approximately $11.5 billion in 2022
Segments:
Global Neurostimulation devices market has been segmented on the basis of type which comprises implantable devices, and external devices. Implantable devices include deep brain stimulators, spinal cord stimulators, sacral nerve stimulators, gastric electric stimulators, cochlear implants, and vagus nerve stimulators; whereas external devices include transcutaneous electrical nerve stimulator, and transcranial magnetic stimulator. On the basis of application, the market is segmented into dystonia, epilepsy, Parkinson's disease, depression, gastroparesis, pain management, tremors, urinary and fecal incontinence, and others. On the basis of end user, market is segmented into hospitals/clinics, cognitive care centers, research institutes and others.
Regional Analysis of Neurostimulation devices Market:
Considering the global scenario of the market, Americas region is believed to be the largest market for Neurostimulation devices. Moreover, the European market is also growing continuously and slowly catching up with the American market. On the other hand, Asia-Pacific market is expected to grow at the fastest pace in the Neurostimulation devices segment during the forecast period. Middle East & Africa region are likely to have a limited but steady growth in the market.
Key Players for Neurostimulation devices Market:                                     
Some of the key players in this market are: Autonomic Technologies, Boston Scientific, ElectroCore, ImThera Medical, Inspire Medical Systems, LivaNova (Cyberonics), Medtronic, NeuroMetrix, NeuroPace, Neuros Medical, NeuroSigma, Nevro Corporation, SPR Therapeutics, St.Jude Medical, Synapse Biomedical, and others.   
Regional Market Summary 
Geographically, the Americas is anticipated to dominate the global Neurostimulation Devices market owing to the rising prevalence of the cardiovascular diseases such as cardiac arrhythmia, arterial blockage, and coronary artery disease among others. The development of the better therapeutic approaches and advanced treatment procedures have affected the growth of the American market in a positive way.
According to the data published by the Department of Health, New York in May 2018, percutaneous coronary intervention is one of the two most common procedures performed on patients with coronary artery disease. Besides this, the high medical awareness among American population, high disposable income, presence of the top medical device manufacturers in the region are some of the many factors that drive the growth of the Neurostimulation Devices market in this region.
Europe is expected to hold the second largest market share in the global Neurostimulation Devices market. The market growth in this region is majorly attributed to the increasing government support for the device manufacturers. Geographical expansion of companies has led to the wider reach of the medical products and services which has brought a huge change in terms of the acceptance and implementation of the new products as well as procedures. Similarly, Asia-Pacific region has observed a rapid growth in the Neurostimulation Devices market owing to the development in the medical sector in developing countries like India and China. Moreover, increase in government funding for healthcare, rising R&D expenditure, and growing number of medical device companies in the region has led to its fastest growth during the forecast period. The Middle East and Africa region is anticipated to show minor growth opportunities in the Neurostimulation Devices market during the forecast period.
Posted by at No comments:

The Sepsis Diagnostics Market Grows Incredibly; Confirms Mrfr Unleashing Industry Prognostications Up To 2022

Sepsis Diagnostics Market– Overview
The development of diagnostic tools for a diverse range of ailments has facilitated the development of the sepsis diagnostic market as well. Market reports connected with healthcare industry have been offered by Market Research Future which creates reports on other industry verticals that intends to analyze the current market scenarios better. The market is on track to attain an 8 % CAGR while earning USD 710 million in the forecast period.
The severity of the symptoms of sepsis necessitate the availability of accurate tests that can detect the ailment at the initial stages. The sepsis diagnostic market is expected to be motivated by the escalating level of investments from industry players. The enhanced collection of patient outcome information and incorporation into medical records is anticipated to additionally inspire the expansion of thesepsis therapeutics market in the forecast period.
Segmental Analysis
The segmental analysis of the sepsis diagnostics market has been carried out on the basis of technology, product type, end-user, and region. Based on technology, the sepsis diagnostic market consists of biomarkers, molecular diagnostics, immunoassays, and others. By type of products, the sepsis market is segmented into instruments, kits, blood culture media, and others. Based on end users, the sepsis diagnostic market is segmented into specialty clinics, hospitals, pathology laboratories, diagnostic centers, and others. The regions that are considered in the sepsis diagnostic market are the Americas, Europe, Asia Pacific, Middle East, and Africa.
Detailed Regional Analysis
The region-based study of the sepsis diagnostic market includes regions such as Americas, Europe, Asia Pacific, Middle East, and Africa. The North American region is the major market for medical tourism which is expected to motivate the development of the sepsis market in the forecast period. The North American market for sepsis diagnostics is anticipated to achieve USD 320 million by the end of the forecasted period. The European region is the next prime market for sepsis diagnostics which is anticipated to develop at the CAGR of 6.8%. While the Asia Pacific region is anticipated to be the most rapidly growing region in sepsis diagnostics market.
Competitive Analysis
The current implementation of strategies is expected to motivate the market in the impending years. The development of a strong value chain is moreover motivating the expansion of the market. The vertical additions and product tactics of the market are enhancing the potential of the market companies. Substantial cutbacks in administrative budgets are bringing further development of the market. The augmented conformity of market players to new clients and market trend predispositions are advancing the growth curve of the market and will continue in the forecast period. The calculated goals envisioned for the market are buoyed due to useful product differentiation supported by market contestants. The expansion of the market is moving in a favorable direction due to original product introductions or escalating gross revenue of the players in the market.
The prominent competitors in the sepsis diagnostic market are EKF Diagnostics (UK), T2 Biosystems, Inc. (US), bioMérieux, Inc. (US), Becton, Dickinson and Company (US), Sandstone Diagnostics, Inc. (US), Immunexpress (US), Axis-Shield Diagnostics Ltd. (Scotland), Cube Dx GmbH (Austria), and others.
Industry Updates:
Dec 2018 Beckman Coulter, which is an international leader in the clinical diagnostics industry has announced that it is joining forces with Sepsis Alliance, the nation's leading sepsis organization, to support the Sepsis Coordinator Network. The pioneering online, peer-to-peer alliance for healthcare professionals, the Sepsis Coordinator Network is dedicated to saving lives by advancing patient results.
May 2018 Mobidiag, a Finnish firm, has obtained funding to creäte a rapid molecular sepsis assay on its Novodiag system. The fresh funding comprises of a €1.5 million ($1.74 million) loan for the first year of the project provided by Business Finland, a funding agency previously known as Tekes.
Posted by at No comments:

Regenerative Medicine Market Staggering Double Digit Cagr Till 2022

Global Regenerative Medicine Market - Overview
The global market for regenerative medicine is growing steadily. Factors that influence the regenerative medicine market are increasing advancement in healthcare technology, increasing prevalence of chronic diseases and the rising growth in stem cell technology is driving the growth of the market.
The demand for biologically derived materials for regenerative medicine is currently high due to its efficiency over other naturally derived materials. During the surgical procedures, synthetic materials are more preferred as they provide better outcome. Increase in demand for material reengineering and cell biology with the recent progress in the design of synthetic materials have led to the use of hydrogel in the formation of tissue-engineered scaffolds.
Furthermore, the increasing incidence of degenerative diseases and shortage of organs for transplantation are expected to boost the growth of the market. The prominent potential of regenerative medicine to replace, repair, and regenerate damaged tissues and organs has boosted the market growth. Moreover, utilization of nanomaterials in wound care, drug delivery, and immunomodulation has spurred the growth avenues for the regenerative medicines market. However, stringent regulatory barriers and high cost of the treatment are likely to hinder the market growth
Numerous government bodies are encouraging the growing regenerative medicine market. For instance, National Institutes of Health (NIH) supports scientific research community through NIH Regenerative Medicine Program, International SC Research, State Initiatives for Stem Cell Research, NIH SC Unit, NIH SC Libraries & Projects, and NIH SC Translation Laboratory. However, identifying the potential clinical applications in countries such as U.S., UK, China, and Japan have introduced changes in their regulatory policies to encourage research. Thus, the industry is projected to reflect accelerated growth over the forecast period.
Globally the regenerative medicine market is expected to grow at the rate of about 25.4% from 2016 to 2022.
Industry Updates
October, 2017 Advanced Medical Solutions Group and Organogenesis Inc. enter into patent out-licensing agreement. The companies have agreed on the US patent on the collagen-based wound dressing containing Polyhexamethylene Biguanide
July, 2017 Baxter International Inc., a global medical products company announced the acquisition of Claris Injectables Limited. The acquisition is expected to broaden Baxter’s presence in the generic pharmaceuticals market and will boost the supply of essential medicines to the customers.
March, 2017 Organogenesis Inc. has acquired NuTech Medical. The newly-formed company has expanded product portfolio for the wound care and surgical biologics markets.
Global Regenerative Medicine Market - Regional Analysis
Global Regenerative medicine market, on the basis of regions is divided into Americas, Europe, Asia Pacific and Middle East and Africa.
North America is estimated with highest share in revenue owing to presence of major players and rapid advances in technology along with high investments in stem cell & oncology research. Furthermore, active presences of organizations such as Alliance for Regenerative Medicine, National Institutes of Health, National Cancer Institute, International Society for Stem Cell Research, and National Stem Cell Foundation that promote R&D of regenerative medicine is expected to further accelerate growth in this region.
Europe is the second-largest market for regenerative medicine. Asia Pacific is projected to witness fastest growth over forecast period owing to high investments in healthcare research by the emerging economies in the region. Advances in stem cell research and presence of flexible regulatory environment for clinical adoption of cell-based regenerative therapies, China and Japan are expected to reflect rapid industrial progress.
Global Regenerative Medicine Market - Company Analysis
The global regenerative medicine market is observed to be highly competitive and fragmented. The key entities are perceived to have high investments in development of regenerative therapies to capture the untapped potential by innovating novel therapies to meet the demand for unmet clinical needs.
In addition, key players are witnessed to focus on oncology & age-related degenerative disorders to compete in the market. Thereby, the industry witnesses a strong pipeline of products in clinical trials, which eventually are expected to drive revenue generation.
Organogenesis Inc. (U.S.), Osiris Therapeutics, Inc. (U.S.), Vericel Corporation (U.S.), Stryker Corporation (U.S.), NuVasive, Inc. (U.S.), Medtronic (Ireland), Acelity (KCI Concepts) (U.S.), Integra LifeSciences (U.S.), Cook Biotech Inc. (U.S.), C.R. Bard (U.S.), RTI surgical (U.S.), Baxter International, Inc. (U.S.), Advanced Cell Technology (U.S.), CryoLife (U.S.), Sanofi (France), BioMimetic Therapeutics (U.S.), StemCells Inc. (U.S.), LifeCell Kinetic Concepts (U.S.) and others are some of the prominent players at the forefront of competition in the global regenerative medicine market and are profiled in MRFR Analysis. 
Posted by at No comments:

Global Digital 3D Printing Market Solid Segment Analyzed By Latest Trends, Growth Rate And 2025 Insight

Market Highlights
Digital 3D Printing Market is expected to have a market value of USD 5,214.8 Million till 2025. The digital 3D printing process involves a systematic evaluation and improvement of the products and services to achieve better quality. Digital 3D printing is related to those who manage the delivery of healthcare services. It seeks to improve the effectiveness of treatment and increase patient satisfaction with the service. It comprises of measurement, assessment, and improvement steps.
Segment Analysis
The Global Digital 3D Printing Market has been segmented based on Component, Material, Technology Application, and End User.
The market, based on component, has been bifurcated into system/device and software/services. The market, based on material, has been segregated into polymers, metal and alloy, ceramics, and others. The market based on technology has been bifurcated into stereolithography, deposition modeling, laser sintering, jetting technology, electron beam melting and others. The market, based on application, has been segregated into dental, prosthetics, orthopedics, medical components, tissue engineering, hearing aids, drug screening, and others. The dental segment has been further segmented into clear aligners and dental implants, dentures, crowns & bridges, and others. The dental implants segment is also classified into endosteal implants and sub-periosteal implants. The prosthetics segment has been further classified into prosthetic implants, hip disarticulation, lower limb/extremity componentry, finger splints, and others. The tissue engineering segment has been further bifurcated into bone and cartilage scaffolds, ligament and tendon scaffolds. The market, based on end-user, has been segregated into hospitals & surgical centers dental clinics & laboratories (offices), pharmaceutical & biotechnology companies and others.
Regional Analysis
The Global Digital 3D Printing Market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and Middle East & Africa.
The Americas led the market and accounted for the largest share in 2018, owing to the presence of major market players, developed healthcare infrastructure, high awareness, and availability of advanced treatment options. For instance, in November 2015, a group of medical researchers from North Carolina’s Wake Forest University developed a method to print the 3D form of custom medications in the configuration of pills. These medical researchers at the university designed 3D printed pills with specific doses according to the medical and biological profile of an individual’s body weight, race, gender, and organ functions to improve the effectiveness and minimize the side-effects.
Europe accounts for the second-largest share in the global digital 3D printing market. The European Union (EU) estimated that around 850,000 medical errors were recorded in hospitalizations. Moreover, the rising pressure to reduce healthcare costs, rapidly increasing technological advancements, and better product and service availability in the region is expected to have a positive impact on the digital 3D printing market in Europe
Asia-Pacific is estimated to be the fastest-growing market during the forecast period due to the rising prevalence of chronic and acute diseases such as HIV, cancer, and diabetes, a large number of research organizations, and the development of new infrastructure to support the healthcare industry are expected to drive the market growth. Moreover, the increasing focus of big pharmaceutical companies to enter into this region is expected to drive the market growth.
The Middle East & Africa digital 3D printing market is segmented into two major regions, namely the Middle East and Africa. The Middle East and Africa have less economic developments and extremely low-income due to which the region accounts for the least market share but is expected to grow with the increasing cases of chronic diseases and demand for better treatments in countries.
Key Players
MRFR recognizes the following companies as the Key Players in the Global Digital 3D Printing Market— Stratasys Ltd (US), 3D Systems, Inc. (the US), EnvisionTEC (US), ExOne (US), General Electric (US), Formlabs (US), Materialise (Europe), Micron Dental (US), Carbon, Inc. (the US), Renishaw PLC (UK).
Key Findings of the Study
  • The Global Digital 3D Printing Market is estimated to grow at USD 5,214.8 Million by 2025 at a CAGR of 20.54% during the assessment period
  • The Americas accounted for the largest share of the global digital 3D printing market due to the existence of medical device companies and the rising prevalence of diseases along with increased adoption of treatment by patients.
  • Based on the component, the system/device segment accounted for the largest market share of 61.51% in 2018.
  • Based on material, the polymer segment accounted for the largest market share of 38.31% in 2018.
  • Based on technology, the stereolithography segment accounted for the largest market share of 31.48% in 2018.
  • Based on application, the dental segment accounted for the larger market share of 22.73% in 2018.
  • On the basis of end user, the hospitals & surgical centers segment accounted for the largest market share of 57.51% in 2018.
Posted by at No comments:

Worldwide Hyperspectral Imaging System Market Ready To Set Outstanding Growth From 2019 To 2025

Market Highlights
According to MRFR analysis, Global Hyperspectral Imaging System Market is expected to register a CAGR of 17.4% during the forecast period of 2019 to 2025 and held a value of USD 10,700 Million in 2018.
Hyperspectral imaging system has wide applications in areas such as art conservation, vegetation, water resource control, archaeology, food quality, forensic medicine, crime scene detection, and forensic medicine. HSI technology is mainly used by the defense sector, government agencies, and non-military application sectors such as agriculture and mineral.
The growth of the global hyperspectral imaging system market is boosted by various factors such as the growing industrial applications of hyperspectral imaging,  Technological advancements in electronics industry, such as sensor design, high spectral resolution, high spatial resolution, compact and lightweight devices, growing prevalence of cancer, and increasing awareness of innovative diagnostics methods.
Additionally, the introduction of innovative products in the market is expected to drive the growth of the market during the forecast period. For instance, In January 2020, Specim, Spectral Imaging Ltd. (Finland), launched Specim’s new AFX10, a compact hyperspectral camera for airborne use. Specim’s new AFX10 is easy to use and can be used to check water quality, estimating the fertilizing need in agriculture, identifying vegetation species, or studying wildlife population
However, the high cost associated with the use of hyperspectral imaging and scarcity of qualified professionals is likely to hamper the growth of the market during the forecast period.
Several market players currently dominate the global hyperspectral imaging system market. The key players are engaged in product launches and strategic collaborations to strengthen their market positions.
Regional Analysis
The Market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.
The Americas held the maximum share in the year 2018, owing to the presence of established key players in countries such as the US and Canada. The hyperspectral imaging system market in the Americas has further been categorized into North America and Latin America, with the North American market further divided into the US and Canada. The European hyperspectral imaging system market has been categorized as Western Europe and Eastern Europe. The Western European market has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The hyperspectral imaging system market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The hyperspectral imaging system market in this region is anticipated to be the fastest growing during the assessment period due to the rising mining activities, and blooming healthcare, agriculture, and biotechnology sector in the region. The hyperspectral imaging system market in the Middle East & Africa has been divided into the Middle East and Africa.
Segmentation
The Global Hyperspectral Imaging System Market has been segmented based on Product, Technology, and Application.
The market, based on product, has been divided into visible/near-infrared (VNIR), short-wave infrared (SWIR), mid-wave infrared (MWIR), long-wave infrared (LWIR). The Visible/Near-Infrared (VNIR) systems segment is likely to be the largest due to the high adoption of visible/near-infrared (VNIR) systems in various industries. The mid-wave infrared (MWIR) segment is predicted to be the fastest-growing due to increasing awareness about the rising adoption of MWIR systems in detecting volcanic vents, industrial gas leaks, or biomass burning events.
The global hyperspectral imaging system market has been segmented, based on the technology, into push broom, snapshot, and others. The push broom segment is anticipated to be the largest segment during the forecast period due to the rising popularity of these devices owing to the simplified illumination requirements, minimized illumination exposure, high spectral resolution, and heat load, and the shorter capturing time.
The applications segment of the global hyperspectral imaging system market surveillance, remote sensing, machine vision/optical, and medical diagnostics. The surveillance segment is likely to hold the maximum share during the forecast period due to the rising adoption of innovative technologies in the defense sector.
Key Players
Some of the Key Players in the Global Hyperspectral Imaging System Market are Headwall Photonics, Inc. (the US), Specim, Spectral Imaging Ltd. (Finland), Norsk Elektro Optikk as (NEO) (Norway), Resonon, Inc. (the US), Corning Incorporated(US), Telops (Canada), Applied Spectral Imaging(US), Bayspec, Inc.(the US), Surface Optics Corporation (US), Chemimage Corporation (US), Cubert GmbH (Germany), Raytheon (US), Galileo Group, Inc.(the US), Hypermed Imaging, Inc.(the US), Inno-Spec (Germany), Camlin Group Ltd. (UK), IMEC (Belgium), XIMEA GmbH (Germany), among others.
Posted by at No comments:

Medical Drones Market Opportunities, Drivers, Manufacturers, Analysis And Forecasts Till 2025

Market Forecast
Medical Drones’ Market is expected to worth USD 398 Million by 2025 and is anticipated to register a CAGR of 24.4% during the forecast period (2019 to2025).
Market Synopsis
Medical drones help in the transport of medical supplies such as vaccines, medications, and medical aids. These drones are deployed in remote or inaccessible areas for the rapid & secure distribution of medical supplies and the war-torn regions from medical facilities. Rising public acceptance of medical drone is also driving the growth in medical drones market demand.
Medical Drones Market Size, In recent years, has been seeking the attention of healthcare providers and governments to offer better healthcare services to remote locations. These drones help in on-time delivery of vaccines, medication, blood, and supplies to the origin and thereby reduce the outbreaks of life-threatening infectious diseases.
How can this technology help in improving safety and care delivery?
  • Bedside medication delivery
  • Effective treatment from the distance
  • Easy reach to an isolated place
  • Pre-treatment facility till the time emergency service arrives at takeover
Most of the key players in the market are focusing on developing medical drones to deliver medical supplies to far distances. For instance, in 2016, a Nevada based start-up Flirtey delivered medical test materials and supplies to and from an offshore vessel. This was the first successful ship to shore delivery in the U.S.
Market Influencer
Increasing investments by key players in R&D is the key factor driving the growth of the Global Medical Drones’ Market.
Market Drivers
  • Rising participation of Governments in various countries: Active involvement of local governments towards the deployment of drone service to remote and isolated areas is boosting the growth of the market. For instance, in 2018, the government of Ghana has signed an agreement with Zipline (US) for the deployment of drones throughout the country to provide medical supplies to untapped regions
  • Increasing application of drone for the supply of medical products such as blood, pharmaceuticals/drugs, and vaccines are anticipated to propel the market growth during the forecast period
  • Technological advancements to improving the accuracy of medical drones during emergency cases backed by R&D activities by key players
Market Restraints
  • Medical drones. Medical drones are not allowed to fly without the permission of the government. Thus, product approval laws are expected to restrict the growth of the medical drone’s market during the forecast period.
Segmentation
By Application
  • Blood Transfer: Rising incidence of severe bleeding deaths is boosting the demand for medical drones. The blood transfer segment is anticipated to show a growth rate of ~24% during the analysis period. According to the MRFR analysis, each year, around 60,000 Americans die from blood loss or hemorrhaging. Moreover, around 2 million people die across the globe.
  • Pharmaceutical/Drugs Transfer: The increasing focus of key medical drones vendors towards the development of drones for medication delivery is boosting the growth of this segment.
  • Vaccines Transfer: This segment is mainly on the drones that are associated with the delivery of the vaccine.
By End-User
  • Emergency Medical Services: This segment held the largest market share in 2018, owing to continues advancements in technology. For instance, in 2019, an automated drone’s delivery company Zipline (US), has planned for the expansion of a medical drone network into Ghana for emergency services.
  • Blood Banks: Owing to poor road conditions, transporting blood in underdeveloped countries is a huge task. Medical drones carry blood, plasma, and platelets from blood banks to remote hospitals and clinics.
By Region
  • Americas: The Americas held the largest regional market in 2018, owing to rising technology advancement. Moreover, the governments in this region are also promoting the acceptance of medical drones, as a result, players are aggressively working to develop advanced drones. In October 2019, United Parcel Services (US) received an authority from the Federal Aviation Administration to deliver medical packages at hospitals across the country.
  • Europe: The European market is expected to be the second-largest market in 2025. The market growth in this region can be attributed to government funding and support to the healthcare sector, coupled with increasing research and development.
  • Asia-Pacific: Asia-Pacific is the fastest-growing region for the medical drones market owing to the improving healthcare infrastructure, rising investments in healthcare, and expansions by market players in the region. Also, countries such as India and China are expected to be the fastest-growing in the region due to the focus of governments towards the adoption of new technologies and faster adoption of best treatment options from developed countries.
  • Middle East & Africa: It is projected to account for the least share of the global market due to an underdeveloped healthcare sector.
Key Players
  • DJI (China)
  • DHL (Germany)
  • Embention (Spain)
  • Flirtey (US)
  • Matternet (US)
  • Vayu (US)
  • Zipline (US)
  • EHang (China)
  • TUDelft (Netherlands)
Posted by at No comments:
Subscribe to: Posts (Atom)